Table 1.
CyclASol 0.05% | CyclASol 0.1% | Vehicle | Restasis | |
---|---|---|---|---|
Randomized patients, n | 51 | 51 | 52 | 53 |
Patients completing the study, n (%) | 50 (98.0) | 50 (98.0) | 48 (92.3) | 52 (98.1) |
Patients discontinuing the study, n (%) | 1 (2.0) | 1 (2.0) | 4 (7.7) | 1 (1.9) |
Reason for discontinuation, n (%) | ||||
Adverse events | 1 (2.0) | 0 | 2 (3.8) | 1 (1.9) |
Subject choice | 0 | 0 | 2 (3.8) | 0 |
Other | 0 | 1 (2.0) | 0 | 0 |